«IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase». Science260 (5115): 1808-1810. 1993. PMID8511589. doi:10.1126/science.8511589.
«Vav is associated with signal transducing molecules gp130, Grb2 and Erk2, and is tyrosine phosphorylated in response to interleukin-6». FEBS Lett.401 (2-3): 133-7. January 1997. PMID9013873. doi:10.1016/s0014-5793(96)01456-1.
«An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells». Oncogene21 (3): 460-74. January 2002. PMID11821958. doi:10.1038/sj.onc.1205100.
«Transmembrane domain of gp130 contributes to intracellular signal transduction in hepatic cells». J. Biol. Chem.272 (49): 30741-7. December 1997. PMID9388212. doi:10.1074/jbc.272.49.30741.
«Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction». J. Biol. Chem.276 (40): 37451-8. October 2001. PMID11468294. doi:10.1074/jbc.M106135200.
«A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor». Eur. J. Biochem.269 (11): 2716-26. June 2002. PMID12047380. doi:10.1046/j.1432-1033.2002.02941.x.
«Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation». J. Biol. Chem.271 (51): 32635-43. December 1996. PMID8999038. doi:10.1074/jbc.271.51.32635.
«SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130». J. Biol. Chem.278 (1): 661-71. January 2003. PMID12403768. doi:10.1074/jbc.M210552200.
«Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation». J. Immunol.165 (5): 2535-43. September 2000. PMID10946280. doi:10.4049/jimmunol.165.5.2535.
«IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase». Science260 (5115): 1808-1810. 1993. PMID8511589. doi:10.1126/science.8511589.
«Interleukin-6 family of cytokines and gp130». Blood86 (4): 1243-1254. 1995. PMID7632928.
«Vav is associated with signal transducing molecules gp130, Grb2 and Erk2, and is tyrosine phosphorylated in response to interleukin-6». FEBS Lett.401 (2-3): 133-7. January 1997. PMID9013873. doi:10.1016/s0014-5793(96)01456-1.
«An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells». Oncogene21 (3): 460-74. January 2002. PMID11821958. doi:10.1038/sj.onc.1205100.
«Transmembrane domain of gp130 contributes to intracellular signal transduction in hepatic cells». J. Biol. Chem.272 (49): 30741-7. December 1997. PMID9388212. doi:10.1074/jbc.272.49.30741.
«Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction». J. Biol. Chem.276 (40): 37451-8. October 2001. PMID11468294. doi:10.1074/jbc.M106135200.
«A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor». Eur. J. Biochem.269 (11): 2716-26. June 2002. PMID12047380. doi:10.1046/j.1432-1033.2002.02941.x.
«Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation». J. Biol. Chem.271 (51): 32635-43. December 1996. PMID8999038. doi:10.1074/jbc.271.51.32635.
«SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130». J. Biol. Chem.278 (1): 661-71. January 2003. PMID12403768. doi:10.1074/jbc.M210552200.
«Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation». J. Immunol.165 (5): 2535-43. September 2000. PMID10946280. doi:10.4049/jimmunol.165.5.2535.
«Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase». J. Immunol.158 (9): 4097-103. May 1997. PMID9126968.